| Literature DB >> 33862667 |
Laura De Nardi1, Giuseppe Abbracciavento2, Giorgio Cozzi2, Luca Ronfani2, Irene Viola1, Lara Bigolin1, Egidio Barbi1,2, Andrea Trombetta1.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 33862667 PMCID: PMC8250840 DOI: 10.1111/apa.15877
Source DB: PubMed Journal: Acta Paediatr ISSN: 0803-5253 Impact factor: 4.056
Demographic data and MASC‐2‐SR and CDI 2‐SF
| SSD group | Control group |
| |
|---|---|---|---|
| Number of patients | 58 (50.4%) | 57 (49.6%) | |
| Mean age ± SD (range) |
15.3 years ± 1.61 (range 13–16) |
15.8 years ± 1.59 (range 13–18) | |
| Males/females | 48.3%/51.7% | 54.4%/45.6% | |
| Mean MASC2‐SR scores with SDs and 95% CIs | |||
| Raw score | 50.8 ± 22.3(45–56.7) |
58.6 ± 20.8 (53.1–64.1) |
|
| T‐score |
0.9 ± 1.4 (CI 0.5–1.2) |
1.3 ± 1.5 (0.9–1.7) |
|
| Mean MASC 2‐SR sub‐domain scores with 95% CIs | |||
| Physical symptoms | 0.6 (0.3–0.9) | 1.3 (0.8–1.7) |
|
| Social anxiety | 0.8 (0.5–1.1) | 1.2 (0.9–1.6) |
|
| Tension and restlessness | 0.6 (0.3–0.8) | 1.3 (0.8–1.7) |
|
| Mean CDI 2‐SF scores with SDs and 95% CIs | |||
| Mean raw score |
49 ± 9 (46.6–51.3) |
55.6 ± 13.1 (52.1–59.1) |
|
| Mean T‐score |
4.7 ± 3.6 (3.8–5.7) |
7.2 ± 5.1 (5.8–8.5) |
|
Abbreviations: 95% CI, 95% confidence interval; SD, standard deviations.